Skip to Content

WATSON 796 (Sulfasalazine 500 mg)

Pill with imprint WATSON 796 is Yellow, Round and has been identified as Sulfasalazine 500 mg. It is supplied by Watson Pharmaceuticals.

Sulfasalazine is used in the treatment of rheumatoid arthritis; ulcerative colitis; inflammatory bowel disease; crohn's disease; alopecia (and more), and belongs to the drug classes 5-aminosalicylates, antirheumatics. There is no proven risk in humans during pregnancy. Sulfasalazine 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 796

Sulfasalazine 500 mg WATSON 796
Sulfasalazine 500 mg WATSON 796  Front
Sulfasalazine 500 mg WATSON 796  Back
Sulfasalazine 500 mg WATSON 796

Sulfasalazine

Imprint:
WATSON 796
Strength:
500 mg
Color:
Yellow
Size:
13.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
5-aminosalicylates
Antirheumatics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
magnesium stearate
corn starch
stearic acid
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide